NCT04743609 RSV Burden in Outpatient and Hospital Settings
| NCT ID | NCT04743609 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Association Clinique Thérapeutique Infantile du val de Marne |
| Condition | RSV Infection |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,900 participants |
| Start Date | 2021-02-08 |
| Primary Completion | 2026-12-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,900 participants in total. It began in 2021-02-08 with a primary completion date of 2026-12-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Strengthening outpatient low respiratory tract infection surveillance to document the burden of Respiratory Syncytial Virus (RSV)
Eligibility Criteria
Inclusion Criteria: * children under 24 months of age (≤) * One of the holders of parental authority signed the consent * Patient affiliated to a social security scheme (Social Security or Universal Medical Coverage) * Acute purulent otitis media (Paradise Criteria) or otorrhea with or withitout associated bronchiolitis Exclusion Criteria: * Age \>24 months * Refusal by one of the parents * Not affiliated to a social security system * Maternal RSV vaccination during the pregnancy of the included child
Contact & Investigator
Robert Cohen
STUDY DIRECTOR
Association Clinique et Thérapeutique Infantile du Val de Marne
Frequently Asked Questions
Who can join the NCT04743609 clinical trial?
This trial is open to participants of all sexes, aged 1 Day or older, up to 24 Months, studying RSV Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04743609 currently recruiting?
Yes, NCT04743609 is actively recruiting participants. Contact the research team at corinne.levy@activ-france.fr for enrollment information.
Where is the NCT04743609 trial being conducted?
This trial is being conducted at Créteil, France.
Who is sponsoring the NCT04743609 clinical trial?
NCT04743609 is sponsored by Association Clinique Thérapeutique Infantile du val de Marne. The principal investigator is Robert Cohen at Association Clinique et Thérapeutique Infantile du Val de Marne. The trial plans to enroll 1,900 participants.